Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Changes in prescribing during drug shortages could increase harm to patients.

Cox AR.

BMJ. 2019 Dec 9;367:l6868. doi: 10.1136/bmj.l6868. No abstract available.

PMID:
31818917
2.

Use of information sources regarding medicine side effects among the general population: a cross-sectional survey.

O'Donovan B, Rodgers RM, Cox AR, Krska J.

Prim Health Care Res Dev. 2019 Dec 10;20:e153. doi: 10.1017/S1463423619000574.

PMID:
31818345
3.

Medication safety - pharmacy's contribution: call for papers.

Cox AR, Routledge PA, Wilkins SJ.

Int J Pharm Pract. 2019 Dec;27(6):477-478. doi: 10.1111/ijpp.12589. No abstract available.

PMID:
31696581
4.

Making medicines safer: analysis of patient reports to the UK's Yellow Card Scheme.

O' Donovan B, Rodgers RM, Cox AR, Krska J.

Expert Opin Drug Saf. 2019 Dec;18(12):1237-1243. doi: 10.1080/14740338.2019.1669559. Epub 2019 Sep 20.

PMID:
31538503
5.

Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines.

O'Donovan B, Rodgers RM, Cox AR, Krska J.

Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1023-1031. doi: 10.1002/pds.4841. Epub 2019 Jun 13.

PMID:
31197912
6.

Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and Wales.

Ferner RE, Ahmad T, Babatunde Z, Cox AR.

Drug Saf. 2019 Mar;42(3):445-451. doi: 10.1007/s40264-018-0738-z.

PMID:
30298309
7.

Amateur endurance athletes' use of non-steroidal anti-inflammatory drugs: a cross-sectional survey.

Rudgard WE, Hirsch CA, Cox AR.

Int J Pharm Pract. 2019 Feb;27(1):105-107. doi: 10.1111/ijpp.12469. Epub 2018 Jul 18.

PMID:
30019790
8.

Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths.

Ferner RE, Easton C, Cox AR.

Drug Saf. 2018 Jan;41(1):103-110. doi: 10.1007/s40264-017-0588-0.

PMID:
28808959
9.

Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: A systematic review.

Khan N, Cox AR, Cotton JM.

Thromb Res. 2016 Jul;143:141-8. doi: 10.1016/j.thromres.2016.05.019. Epub 2016 May 25. Review.

PMID:
27259210
10.

Regulation of herbal drugs: a pragmatic public health approach?

Cox AR.

BMJ. 2014 Jun 24;348:g4156. doi: 10.1136/bmj.g4156. No abstract available.

PMID:
24962966
11.

Adverse drug reactions: when the risk becomes a reality for patients.

Cox AR, Butt TF.

Drug Saf. 2012 Nov 1;35(11):977-81. doi: 10.2165/11636140-000000000-00000.

PMID:
23061775
12.

Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Butt TF, Cox AR, Oyebode JR, Ferner RE.

Drug Saf. 2012 Dec 1;35(12):1159-70. doi: 10.2165/11631950-000000000-00000.

PMID:
23058037
13.
14.

Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters.

Cox AR, Anton C, McDowell SE, Marriott JF, Ferner RE.

Br J Clin Pharmacol. 2010 May;69(5):529-34. doi: 10.1111/j.1365-2125.2010.03637.x.

15.

Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK.

Anton C, Cox AR, Ferner RE.

Drug Saf. 2009;32(12):1135-40. doi: 10.2165/11318940-000000000-00000.

PMID:
19916580
16.

A response to the article on the association between paracetamol/acetaminophen: use and autism by Stephen T. Schultz.

Cox AR, McDowell S.

Autism. 2009 Jan;13(1):123-4; author reply 124-5. doi: 10.1177/1362361308101816. No abstract available.

PMID:
19176580
18.
19.

Colchicine in acute gout: optimal dose of colchicine is still elusive.

Cox AR.

BMJ. 2004 Jan 31;328(7434):288; author reply 289. No abstract available.

Supplemental Content

Loading ...
Support Center